Foghorn Therapeutics Inc. Profile Avatar - Palmy Investing

Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform t…

Biotechnology
US, Cambridge [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Foghorn Therapeutics Inc. (FHTX) to it's peer group.

Peer Group
Loading...
End of FHTX's Analysis
CIK: 1822462 CUSIP: 344174107 ISIN: US3441741077 LEI: - UEI: -
Secondary Listings
FHTX has no secondary listings inside our databases.